<DOC>
	<DOCNO>NCT00454311</DOCNO>
	<brief_summary>The aim study evaluate impact biopsy one two cell preimplantatation genetic diagnosis program ( PGD ) screen aneuploidy . This prospective randomized study perform Instituto Valenciano de Infertilidad Valencia ( Spain ) patientes included clinical program . Our purpose optimize methodology employ laboratory order guarantee optimal implantation pregnancy rate without detrimental effect accuracy efficiency cytogenetic analysis . Patients undergo IVF cycle , embryo biopsy perform day 3 embryo two fashion : patient one cell per embryo retrieve whereas others , 2 cell retrieve good morphology embryos 1 slowl one . In case aneuploidy screen perform FISH chromosome 13 , 16 , 18 , 21 , 22 , X Y. Embryo developmente check every 24 hour chormosomally normal embryo replace uterus day 5 development .</brief_summary>
	<brief_title>The Impact Biopsy 1-2 Cells PGD Program Anueploidy Screening</brief_title>
	<detailed_description />
	<criteria>Patients undergo PGD aneuploidy screen oocyte chromosomes 13 , 16 , 18 , 21 , 22 , X &amp; Y Patients undergo PGD monogenic disease ( PCR ) Patients undergo PGD structural chromosomal abnormality Ovum donation cycle Cryopreserved oocyte/embryos</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Pregnancy implantation rate</keyword>
	<keyword>Efficiency accuracy genetic testing</keyword>
</DOC>